Clinical Trials on CYP2C19 Genotypes in United States
Total 39 results
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Stanford UniversityRecruiting
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
Sequenom, Inc.Sequenom Center for Molecular MedicineCompleted
-
California Pacific Medical Center Research InstituteChildren's Mercy Hospital Kansas CityWithdrawnMethamphetamine Metabolism, CYP2D6 GenotypeUnited States
-
Bristol-Myers SquibbCompletedHCV (Genotype 1)United States, Puerto Rico
-
Sequenom, Inc.NAFTNetCompleted
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...United States
-
Northwell HealthTerminatedHigh Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime ExposureUnited States
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Mayo ClinicNot yet recruitingSide Effect of Drug | Pharmacogenomic Drug Interaction | Drug Metabolism, Poor, CYP2D6-Related | Ineffective Drug Action | Drug Metabolism, Poor, CYP2C19-RelatedUnited States
-
National Eye Institute (NEI)RecruitingRetinal Disease | GenotypeUnited States
-
National Institute of Mental Health (NIMH)CompletedfMRI | Brain Disease | Brain Mapping | Genotype | Allelic Frequencies of Genetic MarkersUnited States
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
University of NebraskaCompletedGenotype 1 Hepatitis C VirusUnited States
-
Presidio Pharmaceuticals, Inc.CompletedChronic Genotype 1 Hepatitis C Virus InfectionUnited Kingdom, Denmark, United States
-
Pacific Health FoundationHoffmann-La RocheCompletedChronic Hepatitis C | Treatment | Asian Americans | Novel GenotypesUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedPain | Genotype | Genetic Variation | Quantitative Sensory Testing (QST) | GCH1United States
-
University of NebraskaTerminatedChronic Hepatitis C | Relapse | Genotype 1United States
-
University of UlsterDSM Nutritional Products, Inc.UnknownParticipants With the MTHFR 677TT GenotypeUnited Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1United States
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 4 | Hepatitis C Viral InfectionUnited States
-
HanAll BioPharma Co., Ltd.CompletedChronic Hepatitis C Infection | Genotype 1United States
-
University College London HospitalsCompletedChronic Hepatitis C, HCV Genotype 1United Kingdom
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis C Virus Genotype 1United States
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Bristol-Myers SquibbCompletedHepatitis C, Genotype 1United States, Australia, France, Germany, Spain, Canada, Puerto Rico, Argentina, Brazil, Russian Federation, United Kingdom, Italy, Belgium
-
GlobeImmuneCompleted
-
Gilead SciencesCompletedChronic Genotype 1a or 1b HCV InfectionUnited States, Canada, Puerto Rico
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Chronic Liver Disease FoundationMerck Sharp & Dohme LLC; SCRI Development Innovations, LLCCompletedChronic Hepatitis C | Genotype 1United States
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1United States, Puerto Rico
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
AbbVie (prior sponsor, Abbott)CompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV)United States, Australia, Canada, France, Germany, New Zealand, Puerto Rico, Spain, United Kingdom
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1United States
-
University of Alabama at BirminghamNational Institutes of Health (NIH); Mereo BioPharmaCompletedEmphysema or COPD | Alpha-1 Antitrypsin Deficiency (AATD) | Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I MutationsUnited States
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Janssen R&D IrelandCompletedHepatitis C Virus Genotype-1United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico